Auspex Pharmaceuticals

Pharma

Teva undercuts rivals with new $60K med Austedo

Under pressure in generics, Teva could use some help from its specialty department, and the newly approved Huntington’s chorea med Austedo could bring just that.

Carly Helfand Apr 4, 2017 9:35am